Codiak Biosciences’ Exosome Therapeutics Attracts Jazz Pharmaceuticals

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 1 (Table of Contents)

Published: 30 Jan-2019

DOI: 10.3833/pdr.v2019.i1.2400     ISSN: 1756-7874

Section: Licensing



Investing in its cancer and haematological portfolio, Jazz Pharmaceuticals has partnered up with Codiak Biosciences to develop exosome therapeutics in a deal worth US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details